Bepotastine clinical trials
How each study uses bepotastine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2011 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 2
Tanabe Pharma Corporation (1) · Asan Medical Center (1) · Hom, Milton M., OD, FAAO (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antihistamines source
Studies
Open first, then newest update. How each study uses bepotastine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic RhinitisCompletedPhase 3Tanabe Pharma CorporationNCT01425632Written as TAU-284How we know
- Effects of Second-generation Antihistamine Bepotastine on Cough Outcomes in Cough Patients With Allergic RhinitisCompletedPhase 4Asan Medical CenterNCT04877678Written as BepotastineHow we know
- Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact LensesStatus unknownPhase 4Hom, Milton M., OD, FAAONCT01337557Written as BepotastineHow we know
Codes
What other systems call bepotastine · ClinicalTrials.gg INT004020
- MeSH (NLM) C108476bepotastineOne source NLM
- UNII (FDA) HYD2U48IASBEPOTASTINEConfirmed FDA, NLM, Wikidata
- RxNorm 863035Confirmed FDA, Wikidata
- Wikidata Q4890915bepotastineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C77431BepotastineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C108476 | bepotastine | One source NLM |
| UNII (FDA) | HYD2U48IAS | BEPOTASTINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 863035 | — | Confirmed FDA, Wikidata |
| Wikidata | Q4890915 | bepotastine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C77431 | Bepotastine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.